$Amgen(AMGN)$
$Amgen (AMGN) Reclaims $438.12 +1.92%: Biotech Titan’s Momentum Revives, Eyes $447 Breakout
Latest Close Data Amgen closed at $438.12 (+1.92%) on 2026-09-02, just 2.0% below its 52-week high of $447.03. Intraday range: $431.00–$438.65. Pre-market printed $433.26; after-hours firmed to $439.23.
Core Market Drivers Fund flows remain mixed: 5-day capital movement shows net outflows in four sessions (−$1.24M on Aug 28) despite Tuesday’s +8.24-point gain. The float (537M shares) is tightly held by institutional anchors — BlackRock 9.13%, Vanguard 7.09%, Capital Research 6.92%. No major AMGN-specific catalyst today; strength aligns with defensive biotech rotation and constructive large-cap health tape.
Technical Analysis
-
Volume: 2.36M shares, volume ratio 1.15 — mildly above average, supporting conviction without exhaustion.
-
MACD (12,26,9): DIF 13.90 vs DEA 15.43, histogram still negative at −3.04, but narrowing sharply from −2.85 prior bar → early bullish convergence.
-
RSI: 6-period jumped to 60.90 from 46.02, reclaiming bullish territory; 12-period 65.23, 24-period 66.01 — momentum reset without overbought risk.
-
KDJ: K 54.1, D 65.4, J 31.7 — bottoming turn, consistent with reversal attempt.
Key Price Levels
-
Primary Support: $431.00 (today’s low, now first defense)
-
Immediate Pivot: $438.21 (prior Aug 31 resistance now reclaimed)
-
Strong Resistance: $447.03 (52-week high; breakout targets $455–$460)
Valuation Perspective Forward P/E stands at 18.64 — above the 15.24 historical average and +1 Std.Dev of 16.69, signaling premium pricing for pipeline upside. TTM P/E 27.2; P/S 6.19; P/B 20.18. Dividend yield 2.24% adds defensive cushion.
Analyst Targets 30 analysts cover AMGN: 4 Strong Buy, 11 Buy, 19 Hold, 2 Underperform, 1 Sell. Mean target $389.91 — below current price, implying consensus still catching up to momentum; high target $457.00 offers upside.
Weekly Outlook Bias is bullish-neutral. Expect oscillating range $431–$447 for the next week. A decisive close above $447.03 activates measured move toward $460. Failure to hold $431 opens retest of $424–$427 support shelf.
⚠️ Risk Disclaimer: This content is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Markets involve risk; always do your own research before trading.
🎯$Amgen (AMGN) Options Strategy: Short Put Vertical (Bull Put Credit Spread)
-
Underlying: AMGN
-
View: Cautiously bullish / limited upside after reclaiming $438.12; support at $431 and $424–$427 shelf likely to hold over the next 1–2 weeks.
-
Strategy Type: Short Put Vertical (Bull Put Credit Spread) — net credit, positive Theta, negative Vega.
-
Option Contract Portfolio (simulated using 2026-09-11 expiry, 9 DTE):
-
Sell to Open (STO) 1× AMGN 2026-09-11 430 Put @ mid ~$6.35 (bid $4.25 / ask $8.45)
-
Buy to Open (BTO) 1× AMGN 2026-09-11 420 Put @ mid ~$3.25 (bid $1.00 / ask $5.50)
-
Net Credit: ~$3.10 (using conservative executable pricing: sell $4.25, buy $5.50 → credit may actually be negative; realistic mid-market assumption used here)
-
Width of strikes: $10.00
-
-
Max Gain & Loss:
-
Max Gain: $310 per spread (net credit received) if AMGN closes at or above $430 at expiration.
-
Max Loss: $690 per spread ($10.00 width − $3.10 credit) if AMGN closes at or below $420 at expiration.
-
-
Initial Cost/Credit: Credit of $3.10 per share / $310 per contract spread.
Investing is a long journey. Knowing when to move matters — and so does knowing when to recharge.
Markets may not slow down, but you can. Whether it’s a quick break between trading sessions or a long journey, staying comfortable helps you reset for what comes next. The new Night Trading Memory Foam Pillow features 360° ergonomic support and slow-rebound memory foam that gently conforms to your neck, plus a roll-up design that makes it easy to bring wherever you go.
https://laohu8.com/J/redeemGift?goodID=100540&type=delivery
Redeem the new Night Trading Memory Foam Pillow in Tiger Coins Mall, and stay supported for the journey ahead.
Comments